CUTTING MORTALITY AND HOSPITALIZATIONS IN HEART FAILURE – (05-18-09)



Omega-3 Fatty Acids, but Not Statin Therapy, Cuts Mortality and Hospitalizations in Heart Failure.

I think the title really states it all. Looking into the data, while not jaw dropping at preventing deaths, the data completely blows away the data on statins. Understand this…this study was done on DEATH, not heart attacks. Statins have not been shown to strongly affect death rates. To prevent even a single heart attack (NOT death) we have to treat in excess of 150 patients for 3 years.

In this study, treating 44 patients was needed for 3.9 years to prevent one DEATH. Then we consider that EFAs are beneficial for a large array of other conditions, are much safer and much cheaper. Again, I reiterate that I do not believe that the statin class of drugs should even exist, let alone generate over $20 billion / year in sales for one single drug company alone.

Read entire article here (note: link to this article may require access).

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Drug Research, Hospital Care
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”